Pronethalol
From Wikipedia, the free encyclopedia
Jump to: navigation, search
![]() |
|
Clinical data | |
---|---|
Routes of administration |
Oral |
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 54-80-8 ![]() |
PubChem | CID 4930 |
ChemSpider | 4761 |
UNII | XBP4RT1IMQ ![]() |
ChEMBL | CHEMBL16476 |
Chemical and physical data | |
Systematic (IUPAC) name: 1-(naphthalen-2-yl)-2-(propan-2-ylamino)ethanol
|
|
3D model (Jmol) | Interactive image |
Formula | C15H19NO |
Molar mass | 229.32 g/mol |
Chirality | Racemic mixture |
|
Pronethalol (Alderlin, Nethalide) was an early non-selective beta blocker clinical candidate. It was never used clinically due to carcinogenicity in mice, which was thought to result from formation of a carcinogenic naphthalene epoxide metabolite.[1]
See also[edit]
References[edit]
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
![]() |
This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |